Patent=WO2009156155A1
Sandig V., Jordan I.
Cell line for propagation of highly attenuated alphaviruses.
Patent number WO2009156155A1, 30-Dec-2009

PubMed=19071186; DOI=10.1016/j.vaccine.2008.11.066
Jordan I., Vos A., Beilfuss S., Neubert A., Breul S., Sandig V.
An avian cell line designed for production of highly attenuated viruses.
Vaccine 27:748-756(2009)

PubMed=19531390; DOI=10.1016/j.vaccine.2009.05.083
Lohr V., Rath A., Genzel Y., Jordan I., Sandig V., Reichl U.
New avian suspension cell lines provide production of influenza virus and MVA in serum-free media: studies on growth, metabolism and virus propagation.
Vaccine 27:4975-4982(2009)

DOI=10.17169/refubium-4684
Ogorek C.
Characterization of the N-glycosylation profile of the new avian cell line AGE1.CR and the modification of fucosylation.
Thesis PhD (2012); Freien Universitat Berlin; Berlin; Germany

PubMed=25903999; DOI=10.1002/biot.201400388
Genzel Y.
Designing cell lines for viral vaccine production: where do we stand?
Biotechnol. J. 10:728-740(2015)

PubMed=26814192; DOI=10.1080/03079457.2016.1138280
Jordan I., John K., Howing K., Lohr V., Penzes Z., Gubucz-Sombor E., Fu Y., Gao P., Harder T., Zadori Z., Sandig V.
Continuous cell lines from the Muscovy duck as potential replacement for primary cells in the production of avian vaccines.
Avian Pathol. 45:137-155(2016)